Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17α- benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: Combination of two substituents at positions C3 and C17α of estradiol

Journal of Medicinal Chemistry

Volumn 42, Issue 12, 1999, Pages 2280-2286

  Ciobanu, Liviu C ^a   Boivin, Roch P ^a   Luu The, Van ^a   Labrie, Fernand ^a   Poirier, Donald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 O SULFAMATE 17BETA HYDROXY 17ALPHA (TERT BUTYLBENZYL)ESTRA 1,3,5(10)TRIENE; 3 O SULFAMATE 17BETA HYDROXY 17ALPHA BENZYLESTRA 1,3,5(10)TRIENE; 3,17BETA DIHYDROXY 17ALPHA (TERT BUTYLBENZYL)ESTRA 1,3,5(10)TRIENE; ENZYME INHIBITOR; STERYL SULFATASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION;

ARYLSULFATASES; CELL LINE; ENZYME INHIBITORS; ESTRADIOL; HUMANS; STERYL-SULFATASE; SULFONAMIDES; TRANSFECTION;

EID: 0033578075     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980677l     Document Type: Article

References (37)

1. (a) Labrie, F.; Bélanger, A.; Simard, J.; Luu-The, V.; Labrie, C. DHEA and peripheral androgen and estrogen formation: intracrinology. Ann. N. Y. Acad. Sci. 1995, 774, 16-28.
2. (b) Labrie, F. Intracrinology. Mol. Cell. Endocrinol. 1991, 78, C113-C118.
3. (a) Pasqualini, J. R.; Gelly, C.; Nguyen, B. L.; Vella, C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 1989, 34, 155-163.
4. (b) Santen, R. J.; Leszczynski, D.; Tilson-Mallet, N.; Feil, P. D.; Wright, C.; Manni, A.; Santner, S. J. Enzymatic control of oestrogen production in human breast cancer: relative significance of aromatase versus sulphatase pathways. Ann. N. Y. Acad. Sci. 1986, 464, 126-137.
5. (c) Loriaux, D.; Ruder, H.; Lipsett, M. The measurement of estrone sulfate in plasma. Steroids 1971, 18, 463-472.
6. (a) Pasqualini, J. R.; Cortes-Prieto, J.; Chetrite, G.; Talbi, M.; Ruiz, A. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int. J. Cancer 1997, 70, 639-643.
7. (b) Pasqualini, J. R.; Chetrite, G.; Blacker, C.; Feinstein, M. C.; Delalonde, L.; Talbi, M.; Maloche, C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre-and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab. 1996, 87, 1460-1464.
8. (c) Pasqualini, J. R.; Chetrite, G.; Le Nestour, E. Control and expression of oestrone sulphatase activities in human breast cancer. J. Endocrinol. 1996, 150, S99-S105.
9. (d) Purohit, A.; Wang, D. Y.; Ghilchik, M. W.; Reed, M. J. Regulation of aromatase and sulphatase in breast tumour cells. J. Endocrinol. 1996, 750, S65-S71.
10. (e) Nguyen, B. L.; Ferme, I.; Chetrite, G.; Pasqualini, J. R. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells. J. Steroid Biochem. Mol. Biol. 1993, 46, 17-23.
11. (a) Purohit, A.; Vernon, K. A.; Wagenaar Hummelinck, A. E.; Woo, L. W. L.; Hejaz, H. A. M.; Potter, B. V. L.; Reed, M. J. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J. Steroid Biochem. Mol. Biol. 1998, 64, 269-275.
12. (b) Chu, G. H.; Jagannathan, S.; Li, P. K. Synthesis of 17-oxoandrosta-3,5-dien-3-methyl sulfonate as stable analogue of dehydroepiandrosterone sulfate. Steroids 1998, 63, 214-217.
13. (c) Li, P. K.; Chu, G. H.; Guo, J. P.; Peters, A.; Selcer, K. W. Development of potent nonestrogenic estrone sulfatase inhibitors. Steroids 1998, 63, 425-432.
14. (d) Romer, W.; Oettel, M.; Schwarz, S. Scavestrogen sulfamates: correlation between estrone sulfatase inhibiting and antioxidant effects. Can. J. Physiol. Pharmacol. 1998, 76, 99-109.
15. (e) Howarth, N. M.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Estrone sulfonates as inhibitors of estrone sulfatase. Steroids 1997, 62, 346-350.
16. (f) Woo, L. W. L.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Oestrone 3-O-(N-acetyl) sulphamate, a potential molecular probe of the active site of oestrone sulphatase. Bioorg. Med. Chem. Lett. 1997, 7, 3075-3080.
17. (g) Chu, G. H.; Li, P. K. Synthesis of sodium androst-5-ene-17-one-3β-methylene sulfonate. Steroids 1997, 62, 543-545.
18. (h) Chu, G. H.; Milano, S.; Kluth, L.; Rhodes, M.; Boni, R.; Johnson, D. A.; Li, P. K. Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors. Steroids 1997, 62, 530-535.
19. (i) Selcer, K. W.; Hedge, P. V.; Li, P. K. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Cancer Res. 1997, 57, 702-707.
20. (j) Huang, Z.; Fasco, M. J.; Kaminski, L. S. Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids. J. Steroid Biochem. Mol. Biol. 1997, 63, 9-15.
21. (k) Wong, C. K.; Keung, W. M. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem. Biophys. Res. Commun. 1997, 233, 579-583.
22. (l) Selcer, K. W.; Jagannathan, S.; Rhodes, M. E.; Li, P. K. Inhibition of placental estrone sulfatase activity and MCF-7 Breast Cancer Cell proliferation by estrone-3-amino derivatives. J. Steroid Biochem. Mol. Biol. 1996, 53, 83-91.
23. (m) Li, P. K.; Milano, S.; Kluth, L.; Rhodes, M. E. Synthesis and sulfatase inhibitory activities of nonsteroidal estrone sulfatase inhibitors. J. Steroid Biochem. Mol. Biol. 1996, 59, 41-48.
24. (n) Purohit, A.; Woo, L. W. L.; Singh, A.; Winterborn, C. J.; Potter, B. V. L.; Reed, M. J. In vivo activity of 4-coumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Cancer Res. 1996, 56, 4950-4955.
25. (o) Woo, L. W. L.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates. J. Med. Chem. 1996, 39, 1349-1351.
26. (p) Reed, M. J.; Purohit, A.; Woo, L. W. L.; Potter, B. V. L. The development of steroid sulphatase inhibitors. Endocrine-Related Cancer 1996, 3, 9-23 and references therein.
27. (a) Poirier, D.; Boivin, R. P. 17α-Alkyl-or 17α-substituted benzyl-17β-estradiols: a new family of estrone-sulfatase inhibitors. Bioorg. Med. Chem. Lett. 1998, 8, 1891-1896.
28. (b) Boivin, P. R. Synthèse chimique d'inhibiteurs de la stéroïde sulfatase et leur activité estrogénique et antiestrogénique. Université Laval, Québec Qc, 1994.
29. (a) Woo, L. W. L.; Howarth, N. M.; Purohit, A.; Hejaz, H. A. M.; Reed, M. J.; Potter, B. V. L. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J. Med. Chem. 1998, 41, 1068-1083.
30. (b) Woo, L. W. L.; Lightowler, M.; Purohit, A.; Reed, M. J.; Potter, B. V. L. Heteroatom-substituted analogues of the active-site directed inhibitor estra-1,3,5(10)-trien-17 one-3-sulphamate inhibit estrone sulphatase by a different mechanism. J. Steroid Biochem. Mol. Biol. 1996, 57, 79-88.
31. (c) Purohit, A.; Williams, G. J.; Howarth, N. M.; Potter, B. V. L.; Reed, M. J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulphamate. Biochemistry 1995, 34, 11508-11514.
32. Li, X.; Singh, S. M.; Labrie, F. Highly efficient nucleophilic addition of alkyl grignard reagents to 17-ketosteroids in the presence of cerium (III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androstene-3-one, an androgen receptor antagonist. Tetrahedron Lett. 1994, 35, 1157-1160.
33. Peterson, E. M.; Brownell, J.; Vince, R. Synthesis and biological evaluation of 5′-sulfamoylated purinyl carbocyclic nucleosides. J. Med. Chem. 1992, 35, 3991-4000.
34. Schwarz, S.; Thieme, I.; Richter, M.; Undeutsch, B.; Henkel, H.; Elger, W. Synthesis of estrogen sulfamates: compounds with a novel endocrinological profile. Steroids 1996, 61, 710-717.
35. Kini, G. D.; Henry, E. M.; Robins, R. K.; Larson, S. B.; Marr, J. J.; Berens, R. L.; Bacchi, C. J.; Nathan, H. C.; Keithly, J. S. Synthesis, structure, and antiparasitic activity of sulfamoyl derivatives of ribavirin. J. Med. Chem. 1990, 33, 44-48.
36. 13C NMR data. Steroids 1997, 62, 674-681.
37. 13C nuclear magnetic resonance study of 17α-substituted estradiols. Steroids 1995, 60, 830-836.